Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03687658 · ClinicalTrials.gov registry record · NA

Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
91
Enrollment target

NCT03687658: Completed NA study, sponsored by Stanford University.

NCT03687658 is a NA study that has completed, run by Stanford University. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03687658, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target

Study Summary

This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain within and outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. This is the fourth phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

Interventions

  • BEHAVIORAL Laddr

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2019-09-12
Est. Completion 2022-08-31
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03687658

The ClinicalTrials.gov registry entry for NCT03687658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Laddr is the first listed.

NCT03687658 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03687658 about?

NCT03687658 is a clinical study titled "Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating". This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain within and outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. This is the fourth phase of a study that aims to i...

What is the current status of trial NCT03687658?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2019-09-12. Estimated completion is 2022-08-31.

What interventions are being tested in trial NCT03687658?

The interventions under investigation include: Laddr (BEHAVIORAL).

Who is sponsoring clinical trial NCT03687658?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.